Figure 5.
Combination treatment of FTD with MEK inhibitors shows additive antiproliferative effects in LIM1215 cells. The viability of LIM1215 cells was determined after cotreatment with FTD and U0126 (A) or FTD and trametinib (B) for 72 h.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.